Tomsk National Research Medical Center Of The Russian Academy Of Sciences
Clinical trials sponsored by Tomsk National Research Medical Center Of The Russian Academy Of Sciences, explained in plain language.
-
Blood test may boost heart Drug's power against AF
Disease control ENROLLING_BY_INVITATIONThis study tests whether checking amiodarone levels in the blood can help prevent atrial fibrillation (AF) episodes better than standard care. About 80 adults with paroxysmal AF will receive amiodarone, and half will have their drug levels monitored to guide dosing. The goal is t…
Phase: PHASE4 • Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New scan could reveal hidden cancer spread
Diagnosis OngoingThis early-phase study is testing a special imaging agent called 99mTc-HYNIC-FAPI to see how it spreads in the body and whether it can help detect metastatic cancer. Fifteen adults with advanced lung, pancreas, breast, or colorectal cancer will receive the agent and then undergo …
Phase: PHASE1 • Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences • Aim: Diagnosis
Last updated May 26, 2026 03:58 UTC
-
New scan could reveal breast cancer type without biopsy
Diagnosis ENROLLING_BY_INVITATIONThis study tests a special radioactive tracer called [99mTc]Tc-DB8 to see if it can help identify breast cancer types based on estrogen receptor status. About 40 adults with primary breast cancer will get a SPECT/CT scan after receiving the tracer. The goal is to see if the trace…
Phase: PHASE2 • Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences • Aim: Diagnosis
Last updated May 26, 2026 03:57 UTC
-
New scan showdown: which imaging test spots brain tumors best?
Diagnosis OngoingThis study looks at two different imaging scans to see how well they find brain tumors (gliomas) in 40 people. Participants get both a SPECT/CT scan and a PET/CT scan within two weeks. The goal is to compare how clearly each scan shows the tumor, which could help doctors choose t…
Phase: NA • Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences • Aim: Diagnosis
Last updated May 26, 2026 03:49 UTC
-
A sharper eye on breast cancer: new scan spots key protein
Diagnosis ENROLLING_BY_INVITATIONThis study tests a special radioactive tracer that binds to HER2, a protein on some breast cancer cells. By using SPECT/CT scans, doctors hope to see how much HER2 is in the tumor without needing a biopsy. The study involves 50 adults with breast cancer and aims to improve how we…
Phase: PHASE2 • Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences • Aim: Diagnosis
Last updated May 22, 2026 14:01 UTC